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uantiﬁcation
a  b  s  t  r  a  c  t
Robust  quantiﬁcation  of analytes  is a prerequisite  for meaningful  metabolomics  experiments.  In  non-
targeted  metabolomics  it is still  hard  to compare  measurements  across  multiple  batches  or  instruments.
For  targeted  analyses  isotope  dilution  mass  spectrometry  is  used  to  provide  a robust  normalization
reference.
Here,  we  present  an  approach  that  allows  for the automated  semi-quantiﬁcation  of metabolites  rela-
tive  to  a fully  stable  isotope-labeled  metabolite  extract.  Unlike  many  previous  approaches,  we  include
both  identiﬁed  and  unidentiﬁed  compounds  in  the  data  analysis.  The  internal  standards  are  detected  in
an automated  manner  using  the  non-targeted  tracer  fate  detection  algorithm.  The  ratios  of  the light and
heavy  form  of these  compounds  serve  as a robust  measure  to  compare  metabolite  levels  across  different
mass  spectrometric  platforms.  As  opposed  to other  methods  which  require  high  resolution  mass  spec-
trometers,  our  methodology  works  with  low  resolution  mass  spectrometers  as commonly  used  in  gas
chromatography  electron  impact  mass  spectrometry  (GC–EI-MS)-based  metabolomics.
We  demonstrate  the  validity  of  our  method  by analyzing  compound  levels  in  different  samples  and
show  that  it  outperforms  conventional  normalization  approaches  in  terms  of  intra-  and  inter-instrument
reproducibility.  We  show  that  a labeled  yeast  metabolite  extract  can  also  serve  as a reference  for  mam-
malian metabolite  extracts  where  complete  stable  isotope  labeling  is  hard  to achieve.
©  2015  The  Authors.  Published  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license. Introduction
Metabolomics, the attempt to measure the levels of all metabo-
ites of a given system under the given conditions, has become
ncreasingly important in biomedical research [1,2]. Metabolomics
ata can be the basis for biomarker discoveries [3], biotechnological
pplications, or metabolic ﬂux analysis [4–7].
However, analytical variance poses problems to the compari-
on of measurements from different runs or instruments, especially
n non-targeted metabolomics. Common data treatments like
otal ion current normalization cannot be used for cross-platform
omparisons and only account for certain types of errors like ﬂuc-
uations in overall sensitivity. Often these techniques are limited
o a set of very similar metabolite proﬁles. Normalization on pool
amples can be performed, but this does not take into account
he potentially different metabolite proﬁles with different matrix
ffects.
 Presented at the 30th International Symposium on Chromatography (ISC 2014),
alzburg, Austria, 14–18 September 2014.
∗ Corresponding author. Tel.: +352 4666446136.
E-mail address: karsten.hiller@uni.lu (K. Hiller).
ttp://dx.doi.org/10.1016/j.chroma.2015.02.025
021-9673/© 2015 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
Analytical variance is best addressed by adding stable isotope-
enriched internal standards to the sample. The addition of
stable isotope-enriched compounds to a sample before mass
spectrometric analysis is referred to as isotope dilution mass spec-
trometry (IDMS). IDMS is commonly used for targeted quantitative
metabolomics. In non-targeted metabolomics many compounds
remain unidentiﬁed and can, thus, not be included in any standard
mixture. However, this shortcoming can be circumvented by using
fully labeled metabolite extracts of a similar sample as reference.
For example, metabolite extracts of fully 13C-enriched yeast, bacte-
ria, plant, algae, and ﬁlamentous fungi have been used successfully
as complex standard mixtures for large scale metabolite quantiﬁ-
cation or determination of sum formulas [8–13]. So far, they have
not been used for automated non-targeted metabolomics.
For liquid chromatography electrospray ionization high resolu-
tion mass spectrometry (LC–ESI–HRMS) data, there are methods
for non-targeted IDMS available for both semi-quantiﬁcation and
identiﬁcation of analytes. Bueschl et al. [13] applied complete iso-
topic enrichment, whereas the isotopic ratio outlier analysis (IROA)
[14] uses partial stable isotopic enrichment. Pairs of labeled and
unlabeled compounds are automatically detected from the typical
isotopic peak patterns. However, these methods are not applica-
ble for low resolution mass spectrometers and hard ionization
techniques like electron ionization (EI) which produce a large
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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umber of fragment ions. Without accurate mass measurements,
ass spectral peak patterns arising from fragmentation often can-
ot clearly be distinguished from isotopic peak patterns. Therefore,
ther means are necessary for the automated and non-targeted
etection of stable isotope-labeled compounds in such data.
Here, we present an approach for GC–EI-MS metabolomics that
llows for the robust normalization or semi-quantiﬁcation of both
dentiﬁed and unidentiﬁed metabolites relative to a spiked-in sta-
le isotope-labeled metabolite extract. We  used a similar approach
s Wu  et al. [9] who applied fully 13C-labeled yeast metabolite
xtract as internal standard. However, their analysis has been very
argeted and did not make use of the information on uniden-
iﬁed analytes. We  overcome this limitation by employing the
on-targeted tracer fate detection (NTFD) algorithm [15] to detect
ll isotopically enriched compounds within a reference mixture in
n automated manner. The intensity ratios of native compounds
nd the corresponding references are then used to normalize ana-
yte levels in the sample of interest. Additionally, the number of
arbon and nitrogen atoms of the unidentiﬁed compounds can be
btained. Using this experimental setup, absolute quantiﬁcation
f identiﬁed compounds is possible as shown by others [9]. We
emonstrate the validity of our methodology by comparing intra-
nd inter-instrument variation to conventional methods.
. Materials and methods
.1. Materials
Chemicals were purchased from Sigma–Aldrich, unless indi-
ated differently. All solvents used were of grade Chromasolv or
etter.
.2. Culture conditions
To produce the fully labeled reference mixture, Saccharomyces
erevisiae strain S90 mating type  ˛ was grown on YPD agar at 30 ◦C
or 48 h. A single colony was transferred to 5 mL  of liquid YPD
edium for an overnight culture, and then to YNB medium con-
aining [15N2]ammonium sulfate and d-[U-13C]glucose (Cambridge
sotope Laboratories, 99% isotopic purity) as sole nitrogen and car-
on source again over night. Cultures were incubated on a rotary
haker (Infors Multitron) at 30 ◦C and 200 rpm. Following another
 mL  YNB labeling culture over night, culture volume was increased
o 100 mL.  Cultures were inoculated at OD600 = 0.1, cell growth
as monitored using a cell density meter (Biowave CO8000) and
etabolites were extracted in mid-exponential growth phase.
S. cerevisiae strain YJM789 was grown on YPD agar at 30 ◦C for
8 h. After an over night culture in 5 mL  liquid YPD medium, a
0 mL  YPD culture was prepared and extracted in mid-exponential
rowth phase.
A549 cells (ATCC CCL-185) were grown in multi-well plates in
MEM medium (Invitrogen) supplemented with 10% (v/v) FBS and
% (v/v) penicillin/streptomycin in an incubator (Sanyo) at 21% O2,
% CO2 at 37 ◦C.
.3. Metabolite extraction and standard addition
The yeast culture was  centrifuged at 3900 × g for 3 min  at −10 ◦C,
he pellet resuspended in 2 mL  extraction ﬂuid (50%, v/v, methanol
n water, −20 ◦C) and transferred to a reaction tube, preﬁlled with
00 mg  acid-washed glass beads (∅150–212 m,  Sigma–Aldrich).
0 mL  of the YPD and 25 mL  of the YNB culture were harvested
t OD600 ≈ 2. Cell lysis was performed using a Precellys24 (Bertin)
omogenizer, equipped with a Cryolys cooling option held at 0 ◦C,
nd the following program: 2 × 30 s at 6800 rpm with 30 s pause in-
etween. After adding 500 L chloroform, thorough mixing, and A 1389 (2015) 112–119 113
centrifugation at 14,000 × g for 5 min  at 4 ◦C, the upper aqueous
phase was used for analysis of polar metabolites. The labeled polar
metabolite extract was  diluted 1:10 in methanol:water (1:1, v:v)
and stored at −80 ◦C until use. The interphase forming during the
extraction was hydrolysed in 1.5 mL  of 6N hydrochloric acid at 99 ◦C
over night. The supernatant was evaporated and the residue was
extracted with 1.5 mL  methanol:water (1:1, v:v) and diluted 1:10
with methanol:water (1:1, v:v).
To generate the library of labeled compounds 30 L of unla-
beled metabolite extract and 4 L of the unlabeled hydrolysate
were measured separately, and in mixture with 30 L and 8 L of
13C15N-labeled polar extract and interphase.
As internal standards for the yeast YJM789 samples 6 L
of 13C15N-labeled yeast S90 polar extract and 10 L interphase
hydrolysate were spiked into 100 L of the polar extract of interest.
A549 cell extract was  prepared from 4 × 105 cells. Cells were
washed with 1 mL  0.9% (w/v) NaCl and quenched with 400 L
methanol (−20 ◦C). After adding 400 L water (4 ◦C), the cells were
scraped off with a cell scraper and the cell suspension was trans-
ferred into an Eppendorf tube containing 400 L chloroform at
−20 ◦C. Tubes were shaken for 20 min  at 1400 rpm and 4 ◦C and
centrifuged for 5 min  at 16,100 × g at 4 ◦C. A detailed protocol is
available in [16]. To 300 L of the aqueous phase, 6 L of uni-
formly 13C15N-labeled S90 polar extract and 10 L of interphase
hydrolysate were added.
2.4. Sample preparation & GC–MS measurement
The metabolite extracts were transferred to glass vials with
micro inserts and dried in a CentriVap vacuum evaporator (Lab-
conco) at −4 ◦C. Automated sample derivatization was  performed
by using a multi-purpose sampler (GERSTEL). Dried samples were
dissolved in 15 L pyridine, containing 20 mg/mL methoxyamine
hydrochloride and incubated at 40 ◦C for 60 min  under shaking. In
a second step, 15 L N-methyl-N-trimethylsilyl-triﬂuoroacetamide
(MSTFA) were added to the samples and they were further incu-
bated at 40 ◦C for 30 min  under continuous shaking.
GC–MS analysis was  performed on an Agilent 7890A GC coupled
to an Agilent 5975C inert XL Mass Selective Detector (Agilent Tech-
nologies). A sample volume of 1 L was injected into a split/splitless
inlet, operating in splitless mode at 270 ◦C. The gas chromatograph
was equipped with a 30 m DB-35MS capillary column with a 5 m
DuraGuard capillary in front of the analytical column (Agilent J&W
GC Column).
Helium was used as carrier gas with a constant ﬂow rate of
1.0 ml/min. The GC oven temperature was held at 80 ◦C for 6 min
and increased to 300 ◦C at 6 ◦C/min. After 10 min, the temperature
was increased at a rate of 10 ◦C/min to 325 ◦C and held for 4 min.
The total run time was 59.167 min.
The transfer line temperature was set to 280 ◦C. The MS  was
operating under electron ionization at 70 eV. The MS  source was
held at 230 ◦C and the quadrupole at 150 ◦C. Full scan mass spectra
were acquired from m/z 70 to m/z 800.
For inter-instrument comparison the samples were also mea-
sured on an Agilent 7890B gas chromatograph coupled to an Agilent
5977A mass spectrometer using the same column type and temper-
ature program.
2.5. Chromatogram preprocessing
Deconvolution of mass spectra, peak picking, integration, and
retention index calibration were performed using the Metabo-
liteDetector software [17]. Compounds were identiﬁed using
an in-house mass spectra library. The following deconvolution
settings were applied: Peak threshold: 5; Minimum peak height:
5; Bins per scan: 10; Deconvolution width: 5 scans; No baseline
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djustment; Minimum 20 peaks per spectrum; No minimum
equired base peak intensity. Retention index calibration was
ased on an C10–C40 even n-alkane mixture.
.6. Generation of compound library for quantiﬁcation
A library of all detected compounds present in the labeled
east extract was generated using an adapted implementation of
he NTFD algorithm [15,8] which implements the following ﬁlters
nd generates compound libraries for MetaboliteDetector. For each
ompound, the isotopically enriched fragments were determined.
herefore, the yeast S90 extracts have been measured in tripli-
ate. The m/z  of the M+0  peak and the highest isotopic peak M+N
ere considered as potential quantiﬁcation ions for the unlabeled
nd labeled form of the corresponding compound. The following
TFD settings were applied: Minimal number of labeled fragments:
; Minimum (maximum) amount of label: 0.1 (0.9); M1  correc-
ion: 0; Maximum fragment deviation: 0.1. Signals at m/z ≤147
ere excluded. As a ﬁlter for proper isotope clusters, the unla-
eled spectrum was required to have an M+1  peak with an intensity
f 0.01 · M0 < M1 < M0. Fragments with an M−1  peak present with
−1 > 0.2 · M0 indicating overlapping fragment ion clusters were
xcluded.
Of the labeled fragments detected, only those which had their
abeled and unlabeled peaks separated by three mass units (M+N
ith N ≥ 3) and had an M+N intensity in the unlabeled spectrum
f MN < 0.05 · M0 were considered for further analysis. The mass
pectra recorded for the mixture of light and heavy compounds,
s well as their corresponding retention indices and quantiﬁcation
ons were collected for quantiﬁcation of the analyte and reference
ompound in the sample of interest. We  used the spectrum of the
ight and heavy mixture instead of those of the pure light or heavy
orm, because it ensures the best spectrum match with the same
nalyte in the sample of interest in which the labeled and unlabeled
orm are ideally present in equal amounts.
.7. IDMS normalization
For the IDMS normalization of analyte levels we calculated the
atio of the summed heavy and light ion intensities. The peak areas
ere obtained from the MetaboliteDetector batch quantiﬁcation in
argeted-mode using the compound library generated in the pre-
ious step and the following settings: RI: 5; Scoring method: RI +
pec; Req. score: 0.7; Compound reproducibility: 1; Required S/N:
; Minimum number of ions: 15; No extended SIC scan.
.8. Validation
We  compared our isotopologue ratios to M+0  intensities nor-
alized to total ion current. For the latter, all intensity values were
ivided by the summed intensity of all peaks in all mass spectra.
his was performed within MetaboliteDetector. The normalized
ntensities of all light quantiﬁcation ions that were chosen for the
sotopologue ratios were summed up. For single internal standard
ormalization all intensities were divided by the summed inten-
ities of the MN peaks of ([U-13C, U-15N]ornithine) 4TMS (used for
JM789, m/z 192, 250, 264, 336, 355, 427) or ([U-13C]malic acid)
TMS (used for A549, m/z 236, 249, 339, 354).
To determine the injection-to-injection variability, the same
erivatized sample was injected three times in a row. For all
etabolites present in the reference library, we calculated the rel-
tive standard deviation of the isotopologue ratios as well as those
f the TIC- and single internal standard- normalized intensities.
For the inter-instrument comparison, a derivatized sample was
njected into two different GC–MS models using the same col-
mn  type and temperature program. The intensities of instrument. A 1389 (2015) 112–119
A were plotted over those of instrument B to show the correla-
tion (Fig. 4B). Normalization was  performed for visualization of the
quantiﬁcation results from the three approaches in a single plot. For
this purpose, every data point was  divided by the range of values
of the respective normalization method.
3. Theory
3.1. Method overview
Our non-targeted IDMS normalization approach is based on a
complex stable isotope labeled metabolite mixture as internal stan-
dard and involves the following steps (Fig. 1):
• Generation of a stable isotope labeled reference mixture.
• Determination of all stable isotope-enriched compounds within
the reference mixture in a non-targeted manner.
• Selection of suitable quantiﬁcation ions for those compounds.
• Spiking the reference mixture into a sample of interest prior to
GC–EI-MS measurement.
• Quantiﬁcation of the native compound relative to the corre-
sponding labeled internal standard.
3.2. Generation of reference mixtures
As a reference mixture, we used a metabolite extract from a fully
isotopically enriched yeast culture, because it provides a reference
for a large number of known and unknown compounds. For that
purpose, we cultivated yeast in a batch culture on deﬁned minimal
medium containing 13C and 15N substrates. As opposed to earlier
studies [19,9,8], we  performed simultaneous 15N- and 13C-labeling
in an attempt to further separate high and low mass variant of our
analytes. If isotopic peak clusters of the high and low mass variant of
a fragment are overlapping, this fragment cannot be used for quan-
tiﬁcation. This matters for subsequent GC–MS analysis where polar
analytes are often alkylsilylated to increase their volatility. The rel-
atively high natural abundance of silicon isotopes and the large
number of alkylcarbons introduced into the molecule increase the
abundance of isotopic peaks. Simultaneous labeling of both 15N as
well as 13C reduces the number of cases where isotopic peaks of the
derivatized labeled and unlabeled metabolites overlap and, there-
fore, cannot be used for quantiﬁcation. Apart from this reduced
number of quantiﬁcation fragments, the presented method can also
be used with 13C-labeling alone.
This isotopically enriched yeast culture was  homogenized and
metabolites were extracted using a methanol, water, chloroform
mixture. During the extraction process three phases form: A chlo-
roform phase containing non-polar metabolites, an aqueous phase
containing polar metabolites, and an interphase containing pre-
cipitated proteins and nucleic acids. We  were only interested in
metabolites of the polar phase and used this phase as the refer-
ence mixture. Additionally, we performed an acid hydrolysis of
the interphases formed during the extraction (see Section 2 for
details) and supplemented the previous polar extract with this
mixture to increase the concentration of free amino acids and
nucleobases.
3.3. Detection of labeled compounds
We  detected all labeled compounds within the spike-in extract
in a non-targeted and automated manner using the NTFD algo-
rithm (Fig. 1a–e) [15]. For this purpose, an unlabeled yeast extract
as well as a mixture of labeled and unlabeled extract were mea-
sured. NTFD matches and subtracts the spectra of each analyte
found in both samples and detects isotopic enrichment as peaks
D. Weindl et al. / J. Chromatogr. A 1389 (2015) 112–119 115
Fig. 1. Experimental setup. (a) A reference organism is grown simultaneously in deﬁned medium and in a medium where all carbon and nitrogen sources are substituted
by  their fully stable isotope-labeled analogues. (b) Metabolites are extracted using water:methanol:chloroform. The protein- and nucleic acid- containing interphase is
hydrolyzed, pooled with the polar metabolites and used as reference extract. (c, d) NTFD is used to detect all stable isotope-labeled compounds and fragments, as well as
the  m/z ratios of their light and heavy isotopologues. Therefore, the unlabeled extract and a mixture of labeled and unlabeled extract are measured with GC–EI-MS. (e) The
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nterest. (f, g) An aliquot of the labeled reference mixture is added to a sample of i
ompounds. The ratios of the intensities of light and heavy forms for each analyte p
n the resulting difference spectrum [15]. The output is a list of all
table isotope-enriched compounds and the m/z ranges as well as
he mass isotopomer distributions for all enriched fragments
.4. Selection of quantiﬁcation ionsOnce we determined the m/z  ranges of the labeled fragments via
TFD, we selected potential quantiﬁcation ions for the labeled and
nlabeled compounds (Fig. 1e). The ﬁrst peak (M+0, in formulas
0) of the isotope cluster arises from the unlabeled isotopologue
ig. 2. (A) Schematic mass spectra of an analyte in the unlabeled sample, in the fully isoto
pectrum of the heavy isotopologue, the labeled fragments are shifted towards higher m
eaks  are also present in the mass spectrum of the fully labeled metabolite. (a) The small 
f  the natural isotope clusters of the forms. Such fragments were not used for quantiﬁcat
hese  ions unsuitable for quantiﬁcation. (c, d) Natural isotope clusters of light and heavy
/z  difference of light and heavy form provides the number of isotopes contained in the
nternal standard. The information from all suitable fragments are combined for a more r
 represent N of the MN peak in the respective fragments. reference library to be used to match and quantify compounds within a sample of
t. (h, i) The previously determined ions are used for quantiﬁcation of the detected
e a robust measure for the comparison of metabolite amounts across experiments.
and, thus, represents the native compound from the sample of
interest. As corresponding reference quantiﬁcation ion, we selected
the most abundant peak (M+N, in formulas MN) of the remaining
isotope cluster, which arises from the maximal 13C- and 15N-
incorporation (Fig. 2A-c, d).
In low-mass fragments or in spectra of small metabolites, there
is often an overlap of the natural isotope clusters of the unla-
beled and 13C15N-labeled compound (Fig. 2A-a). Such overlapping
fragments impair the IDMS-based quantiﬁcation and, hence, were
excluded if the M+N abundance in the spectrum of the unlabeled
pically labeled reference mixture, and in an equimolar mixture thereof. In the mass
ass. Due to the natural isotope abundance in the derivatization reagents, isotopic
m/z difference between light (M0) and heavy (MN) isotopologues causes an overlap
ion. (b) Multiple fragments of the unlabeled compound are overlapping, rendering
 forms are well-separated. These fragments can be used for quantiﬁcation. (B) The
 given fragment. (C) Analyte levels are quantiﬁed relatively to the corresponding
obust result. Mi,j denotes the intensity of the jth isotopic peak of fragment i; m and
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Fig. 3. (A) Number of potential internal standards in reference mixture and number
of  matching compounds in different sample types. Comparison of measurements
from two  separate GC–MS instruments. (B) Classes of metabolite derivatives which16 D. Weindl et al. / J. Chrom
ompound was over 5% of M+0. A slight overlap was accepted to not
xclude spectra solely because of possible small impurities. How-
ver, if this M+N signal is not analytical noise but an isotopic peak,
his needs to be considered for large M0/MN ratios in the sample
f interest. In case, the abundance of the labeled compound is very
ow as compared to the unlabeled compound, even low natural iso-
opologue contribution will heavily inﬂuence the intensity ratio.
s additional ﬁlter, quantiﬁcation ions in overlapping fragments
ithin the spectrum of the unlabeled compound (Fig. 2A-b) were
xcluded. All remaining ion pairs of each spectrum were used for
uantiﬁcation. The number of quantiﬁcation ion pairs retained per
ompound ranged from one to seven, with an average of two.
Furthermore, the selected quantiﬁcation ions hold informa-
ion on the elemental composition. The mass difference N of the
etected light (M+0) and heavy (M+N) ions provides the combined
umber of carbon and nitrogen atoms in each of these fragments.
his information is very valuable for unidentiﬁed compounds.
owever, due to the hard electron ionization this number does
ot necessarily correspond to the number of carbon and nitrogen
toms of the underivatized compound. Nevertheless, it is helpful as
 lower bound and in practice the number of atoms is often correct,
ecause in the heavier fragment ions the atoms lost during frag-
entation are often derived from the derivatization reagent which
oes not contribute to the mass shift. For fragments of which the
lemental composition was known [19], the number of carbon and
itrogen atoms matched the mass difference of the light and heavy
ons (Supplemental Table S1). The low mass spectrometric resolu-
ion did not have any negative impact on the determination of the
umber of carbon and nitrogen atoms.
.5. Quantiﬁcation
All isotopically enriched spectra and quantiﬁcation ions selected
n the previous step were collected in a reference library. This
ibrary was subsequently used in a targeted analysis to quantify the
+0  and M+N abundance of those compounds within the sample
f interest (Figs. 1i and 2C).
From these data, we calculated the ratio of the summed inten-
ities of all M+0  and M+N peaks:
 =
∑
M0∑
MN
The use of multiple fragments makes the quantiﬁcation more
obust. The relative contribution of the different fragments
ncreases with their signal intensity.
. Results and discussion
.1. Analysis of the reference mixture
The yeast strain used, grows in a medium containing one single
arbon and nitrogen source, so that we obtained nearly completely
3C- and 15N-labeled metabolite extracts from yeast grown on
U-13C]-d-glucose and [15N2]ammonium sulfate. The remaining
2C14N fraction arises from impurities of the tracers (Supplemental
igure S2). To determine compounds in our reference mixture that
ualify as internal standards, we performed GC–MS measurements
f the 13C15N-labeled yeast extract to create a reference library
s described above. We  generated two datasets on two different
C–MS instruments to later be able to assess inter-instrument
ariation. Below, numbers are presented as “result instrument
” (“result instrument B”). In the reference yeast extract, 179
163) deconvoluted mass spectra were detected in each of three
eplicate measurements (Fig. 3A). Of these mass spectra 109
134) were isotopically enriched and had at least one pair ofwere detected in the reference mixture and for which suitable quantiﬁcation ions
were found (compound numbers are means of measurements on two GC–MS instru-
ments).
quantiﬁcation ions meeting the requirements described above.
Among the excluded compounds, there were known contaminants
and isotopically enriched compounds with overlapping fragments.
The generated yeast extract, thus, provides internal standards
for more than 100 compounds and its preparation is relatively
low priced and easy. About one third of the potential internal
standards have been identiﬁed using an in-house mass spectra
reference library as methyloxime- and trimethylsilyl-derivatives
of about 40 different metabolites (Supplemental Table S1). Among
the identiﬁed compounds, amino acid derivatives were the most
prominent class (Fig. 3B).
For long-term use of the same reference mixture, the stability
of its constituents needs to be considered. We  did not assess long-
term stability of the yeast extract, but for other matrices metabolite
levels have been shown to be stable for storage periods of at least
6 months and multiple freeze thaw cycles [20]. Therefore, we trust
that the majority of compounds is stable also over extended storage
periods if aliquots are frozen at −80 ◦C, and repeated freeze–thaw-
cycles and exposure to higher temperatures are avoided.The complete stable isotope enrichment of a reference organ-
ism could even be circumvented by a different labeling strategy:
Any unlabeled reference mixture could be derivatized with a sta-
ble isotope-labeled silylating reagent suitable for GC–MS sample
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reparation before spiking it into the conventionally derivatized
ample of interest. Such a differential derivatization and mixing
f two samples has been presented before by Huang and Reg-
ier [21]. It has the advantage, that always the sample type of
nterest can be used as a reference and that no fully isotopi-
ally enrichable organism as reference is required. A disadvantage,
owever, is that also any contamination introduced during the
ample workup or exogenous compounds, for example stemming
rom growth medium, will also be derivatized and cannot be dis-
inguished from endogenous metabolites. Furthermore, currently,
here are only deuterated but no 13C-labeled silylating reagents
ommercially available. The pronounced isotope effect of deu-
erium on chromatographic retention increases chromatographic
ample complexity, which is not the case with 13C- and15N-labeling
Supplemental Figure S3). Moreover, highly deuterated derivatiza-
ion agents can lead to very dissimilar mass spectra and render
pectrum matching more complex, thereby hampering any auto-
ated non-targeted analyses.
.2. Applicability to different sample types
As a test case, we used a fully labeled yeast extract to quantify
ompounds within a metabolite extract of a different yeast strain.
or 44 (52) compounds out of the 109 (134) compounds in the ref-
rence library, we detected both the light and heavy form in the
ample of interest (Fig. 3A, Supplemental Table S1). Many of the
nalytes for which there was a labeled analogue in the reference
ixture were not found in the sample of interest. This is mostly
ue to two facts: Firstly, the sample of interest was only the polar
etabolite extract alone without the hydrolysis products added to
he reference mixture. Secondly, for the generation of the quantiﬁ-
ation library, the injected amount of reference mixture was higher
han that of the sample of interest. We  chose to rather overload
he measurements of the reference mixture to obtain a more com-
rehensive library, because analytes which were not detected at
hat stage, could not have been included in subsequent analyses.
onsidering the price and availability of stable isotope labeled ana-
ogues which would have to be acquired otherwise, the number of
eference compounds is respectable.
As the overlap of the reference mixture with the yeast sam-
le was reasonably good, we were interested in the applicability
o mammalian cell extracts. Mammalian cells cannot easily be
ompletely labeled with stable isotopes because of their complex
utrient requirements. To assess the applicability of a yeast extract
or the quantiﬁcation of metabolites in mammalian samples, we
piked the fully labeled reference mixture into a polar metabo-
ite extract derived from human A549 lung cancer cells. This way
e were able to normalize 40 (46) compounds present in the
549 extract. Thereof, 32 compounds were identiﬁed (Supplemen-
al Table S1). The number and identity of compounds common to
eference mixture and sample of interest were similar for yeast
nd human extracts. Although generally the two  organisms dif-
er signiﬁcantly, the difference in detected analytes was  relatively
mall, because GC–MS mostly covers primary metabolites which
re highly conserved across species. This makes our approach appli-
able for a wide variety of samples.
This normalization approach is restricted to compounds that
re present in both sample of interest and reference mixture, for
ompounds not present in the reference mixture only the raw
ignal intensities are available. Therefore, an adequate reference
etabolome has to be chosen. Ideally, the same type as the sample
f interest but isotopically enriched would be used. However, this
s impossible for body ﬂuids, tissue samples, or cells with complex
ubstrate requirements. To optimize the reference mixture and to
ncrease the overlap with the sample of interest, different extracts
rom different organisms or different growth conditions can be A 1389 (2015) 112–119 117
combined. For individual missing but important compounds, a sta-
ble isotope labeled analogue can be added to the reference mixture.
It is preferable to choose a reference as similar as possible to the
sample of interest to maximize the overlap of both composition
and metabolite concentrations. If metabolite concentrations differ
strongly, it is less likely that both of them will lie within the linear
range of the detector. We  showed, however, that yeast metabo-
lite preparations can also be used, to a certain degree, as internal
standard for different samples like mammalian cells. In the ana-
lyzed samples, the levels of most analytes and respective internal
standards differed by less than factor 5 (Supplemental Figure S1).
4.3. Better intra-instrument reproducibility
Our quantiﬁcation approach aims at making non-targeted
metabolomics analyses more robust and comparable across
measurements performed at different times or on different instru-
ments. Thus, we chose intra- and inter-instrument variation as
performance measure to compare our IDMS approach to conven-
tional methods.
As reference methods we  have chosen normalization to a sin-
gle internal standard and normalization to summed signal or
total ion current (TIC). TIC normalization divides the intensity of
every compound in a sample by the summed signal of all com-
pounds in this sample. This normalization approach is commonly
used in metabolomics analyses [22]. For single internal standard
normalization all signal intensities are divided by that of the iso-
tope labeled internal standard. For the single internal standard
we chose one compound from the reference mixture: ([U-13C,U-
15N]ornithine) 4TMS for the yeast and ([U-13C]malic acid) 3TMS
for the A549 sample. These two were selected because they showed
a good peak shape and abundance in the respective samples, and
there were no other derivatives of these metabolites detected.
To assay intra-instrument variation, we determined the rel-
ative standard deviations (RSDs) across three injections of the
same sample (Fig. 4A). For some compounds RSD was rather high,
because of their very low abundance. Overall, the IDMS normaliza-
tion was more robust than the two conventional approaches. With
the yeast samples, mean injection-to-injection variability across
analytes (RSD) decreased signiﬁcantly by 8.56 percentage points as
compared to TIC normalization (paired t-test, p = 0.00402, n = 52).
Single internal standard normalization performed better than TIC
normalization, but RSDs from the IDMS normalization were still sig-
niﬁcantly lower by 5.55 percentage points (p = 0.0048). For human
cell samples there was a similar trend. RSDs after IDMS  normaliza-
tion were 8.82 percentage points lower than after TIC normalization
(p = 0.0219, n = 40) and 1.43 percentage points lower than after
normalization to single internal standard (not signiﬁcant). These
results validate our automated choice of quantiﬁcation ions and the
subsequent quantiﬁcation term. The improvement for both, yeast
and human samples demonstrates that the yeast extract can also
be successfully applied to different sample types.
The IDMS approach would improve reproducibility even more
on platforms without automated sample preparation where differ-
ent derivatization times occur. Ratios of different derivatives of a
single analyte change over time and impact quantiﬁcation results.
However, the individual internal standards are subject to the same
conditions and correct for such biases.
4.4. Better inter-instrument reproducibility
A strong motivation for this quantiﬁcation approach was  the
need for a comparable measure of metabolite levels across dif-
ferent instruments. Measurements on different instruments are
subject to differently aged inlets, chromatography columns, ion
sources or detectors which can heavily inﬂuence the results and
118 D. Weindl et al. / J. Chromatogr. A 1389 (2015) 112–119
Fig. 4. Comparison of the described IDMS approach with summed sample signal normalization and single internal standard (IS) for two different sample types. (A) Isotopologue
ratios  with individual internal standards (IDMS) show lower relative standard deviations across analytes than normalization to summed signal or single internal standard.
The  same sample was  injected three times. Axes are logarithmic. :  Difference of the means of the respective method to IDMS, p: paired t-test p-value. (B) Metabolite
levels  determined on instrument A plotted over those determined on instrument B. The diagonal corresponds to identical quantiﬁcation results. Inter-instrument-variation
is  indicated by the distance of the points from the diagonal and is mostly lower for the isotopologue ratios. Relative sample signal and isotopologue ratios were divided by
their  range to match the different scales. Axes are logarithmic. Summed signal normalization can introduce systematic errors, as visible by the global “upward shift” of the
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otted  lines represent 10% deviation from the diagonal.
amper comparability with other measurements. To assess inter-
nstrument-variations we analyzed two measurements of the same
ample performed on two different GC–MS instruments (Fig. 4B).
he measurements were performed on two GC–MS instruments
ith the same conﬁguration so that TIC normalization would not
e excluded per se.  Quantiﬁcation results of the yeast samples
sing the IDMS-normalization showed lower random differences
etween the two instruments as compared to TIC- and single
nternal standard normalization (Fig. 4B). In the analysis of the
549 samples, TIC-normalization seemed to introduce a system-
tic error: In the measurement on instrument B, most compounds
howed higher levels than on instrument A. This was partially
orrected for with the single internal standard normalization. Iso-
opologue ratio- normalized metabolite levels showed the best
orrelation across the two instruments.Summed signal normalization is sensitive to detector satura-
ion and background signals from contaminations as for example
ntroduced from derivatization reagents. These factors alter the
ummed signal intensity in a sample-independent manner andoment correlation coefﬁcient of the natural logarithm of the normalized intensities.
may  introduce an error in the quantiﬁcation results. Single inter-
nal standard addition is less sensitive to overall background signal
and to individual high abundant compounds leading to detector
saturation. However, a single internal standard cannot sufﬁciently
represent all analyte-speciﬁc analytical discrimination. In contrast,
the isotopologue ratios are very robust, because the analyte of inter-
est and the internal standard are subject to the very same analytical
conditions and the ratios are not inﬂuenced by discrimination of
certain compound classes due to for example deteriorating inlet or
column performance.
5. Conclusion
The method presented here allows for the robust quantiﬁca-
tion of both identiﬁed as well as unidentiﬁed metabolites relative
to a spiked-in complex mixture of stable isotope-labeled com-
pounds. Such a mixture can easily be produced in-house from any
prototrophic organism [9,8] or commercial 13C-enriched extracts
can be used [10]. All potential internal standards are detected
atogr.
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sing the NTFD algorithm [15] and suitable quantiﬁcation ions are
ssigned automatically. Hence, it is easy to use, also in cases of very
omplex reference mixtures. Later on, absolute quantiﬁcation of
nown compounds can be achieved by including compound mix-
ures of known concentration in the measurements as shown in
revious studies [9].
To our knowledge, the approach presented in this manuscript is
he ﬁrst description of an automatable workﬂow for non-targeted
DMS for GC–EI-MS analysis or low resolution mass spectrome-
ry in general. Previous approaches employing labeled metabolite
xtracts were always targeted and did not consider unidentiﬁed
ompounds. Operating in a non-targeted manner would otherwise
equire signiﬁcant user effort to manually examine all deconvo-
uted mass spectra for isotopic enrichment and to compare labeled
nd unlabeled mass spectra to pick proper quantiﬁcation ions.
Often, initially unidentiﬁed compounds turn out to be of inter-
st in subsequent experiments. With the technical advancement,
rowing compound libraries, and better matching algorithms [23]
hey can be identiﬁed later on. When such compounds happen to be
dentiﬁed at a later date, also their absolute quantiﬁcation is pos-
ible retroactively with our method as all measurements already
ontain the respective internal standard.
The isotopic peak ratios are not only more robust than con-
entional normalization methods in a run-to-run comparison, but
lso allow for comparison of analyte levels across measurements
erformed at different times and on different instruments or
ven laboratories. Low analytical variance is crucial for meaning-
ul non-targeted metabolomics and with better inter-instrument
omparability larger metabolomics studies can be realized better.
We implemented the described procedure for the automated
eneration of the reference library with appropriate quantiﬁcation
ons as a new feature in the NTFD application [8] which is freely
vailable for download from http://ntfd.mit.edu/. The generated
ompound library can be used with the freely available Metabolit-
Detector software [17] to integrate the signal intensities of these
uantiﬁcation ions in the samples of interest. Automated calcu-
ation of the isotopologue ratios will be included in subsequent
eleases of MetaboliteDetector.
upplemental information
Supplemental Figures S1–S3 and a list of detected compounds
nd quantiﬁcation ions (Supplemental Table S1) are available
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